|Articles|December 1, 2019
- Pharmaceutical Executive-12-01-2019
- Volume 39
- Issue 12
Pharmaceutical Executive, December 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Market Access: Employers as Barriers to Valueover 6 years ago
Lundbeck's Taj Bhardwaj: Market Access and Mental Healthover 6 years ago
The Route to Market Access in Europeover 6 years ago
A Multi-Stakeholder Perspective On Assessing Drug Valueover 6 years ago
When the Patient Loses in Market Accessover 6 years ago
Making Sense of Copay Accumulatorsover 6 years ago
Year in Review: R&D, Regulatory, and Reimbursement Hurdlesover 6 years ago
Who’s Going to Choose Where to Launch a Drug?over 6 years ago
Back to the Basics?over 6 years ago
Focus Report: Puerto RicoNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
3
What Governance Resets Should Pharma Companies Take in Response to AI?
4
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
5